Home › NDC Lookup › RxCUI directory › RxCUI 885857

Balsalazide disodium 750 MG Oral Capsule — RxCUI 885857

RxNorm drug concept · Semantic clinical drug
RxCUI 885857 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI885857
Official nameBalsalazide disodium 750 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped9
Package NDCs mapped12
Reported Medicaid activity (SDUD)8,799 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Balsalazide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Balsalazide is an anti-inflammatory medication designed specifically to work in your colon. It travels through your digestive system mostly unchanged until bacteria in the colon br...
  • What exactly is balsalazide and what does it do for ulcerative colitis?
  • Yes — if you or your child can't swallow the capsule whole, you can open it and sprinkle the contents onto a small amount of applesauce. Just make sure to chew and swallow the whol...
  • Can I open the capsule if I have trouble swallowing it?
📖 Read our full Balsalazide guide →

🕸️ Concept Web — How Balsalazide disodium 750 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Balsalazide disodium 750 MG Oral Capsule RxCUI 885857

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Balsalazide 18747
    • Balsalazide disodium 153718
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Colazal 284700
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Balsalazide Oral Capsule 374634
    • Balsalazide disodium Oral Capsule 2649562
    • Balsalazide Oral Product 1158855
    • Balsalazide Pill 1158856
    • Balsalazide disodium Oral Product 2661914
    • Balsalazide disodium Pill 2659761
    • Balsalazide Oral Capsule [Colazal] 366549
    • Balsalazide disodium Oral Capsule [Colazal] 2654303
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Balsalazide disodium 750 MG 885856
    • Balsalazide disodium 750 MG Oral Capsule [Colazal] 885859
    • Balsalazide disodium 750 MG [Colazal] 885858

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Balsalazide disodium 750 MG SCDC · 885856
  • Balsalazide Oral Capsule SCDF · 374634
  • Balsalazide disodium Oral Capsule SCDFP · 2649562
  • Balsalazide Oral Product SCDG · 1158855
  • Balsalazide Pill SCDG · 1158856
  • Balsalazide disodium Oral Product SCDGP · 2661914
  • Balsalazide disodium Pill SCDGP · 2659761

Brand-Name Concepts

  • Balsalazide disodium 750 MG Oral Capsule [Colazal] SBD · 885859
  • Balsalazide disodium 750 MG [Colazal] SBDC · 885858
  • Balsalazide Oral Capsule [Colazal] SBDF · 366549
  • Balsalazide disodium Oral Capsule [Colazal] SBDFP · 2654303
  • Colazal Oral Product SBDG · 1176459
  • Colazal Pill SBDG · 1176460
  • Colazal BN · 284700

📦 FDA Products & Package NDCs

9 products · 12 package NDCs
12 package NDCs map to RxCUI 885857 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0079-28 280 CAPSULE in 1 BOTTLE (0054-0079-28) Balsalazide Disodium Hikma Pharmaceuticals USA Inc. 2007-12-28
50268-0102-13 30 BLISTER PACK in 1 BOX (50268-102-13) / 1 CAPSULE in 1 BL... Balsalazide Disodium AvPAK 2014-11-06
51407-0820-28 280 CAPSULE in 1 BOTTLE (51407-820-28) Balsalazide Disodium Golden State Medical Supply, Inc. 2023-07-14
60505-2575-00 10 BLISTER PACK in 1 CARTON (60505-2575-0) / 10 CAPSULE in... Balsalazide Disodium Apotex Corp. 2007-12-28
60505-2575-03 30 CAPSULE in 1 BOTTLE (60505-2575-3) Balsalazide Disodium Apotex Corp. 2007-12-28
60505-2575-04 350 CAPSULE in 1 BOTTLE (60505-2575-4) Balsalazide Disodium Apotex Corp. 2007-12-28
60505-2575-07 280 CAPSULE in 1 BOTTLE (60505-2575-7) Balsalazide Disodium Apotex Corp. 2007-12-28
70710-1626-01 280 CAPSULE in 1 BOTTLE (70710-1626-1) balsalazide disodium Zydus Pharmaceuticals (USA) Inc. 2023-08-25
70771-1841-01 280 CAPSULE in 1 BOTTLE (70771-1841-1) balsalazide disodium Zydus Lifesciences Limited 2023-08-25
72162-2095-02 280 CAPSULE in 1 BOTTLE (72162-2095-2) Balsalazide Disodium Bryant Ranch Prepack 2007-12-28
72789-0149-69 280 CAPSULE in 1 BOTTLE, PLASTIC (72789-149-69) Balsalazide Disodium PD-Rx Pharmaceuticals, Inc. 2020-12-02
80005-0126-25 280 CAPSULE in 1 BOTTLE (80005-126-25) balsalazide disodium Carnegie Pharmaceuticals, LLC 2025-06-30
Observed labelers: Apotex Corp. (4) · AvPAK (1) · Bryant Ranch Prepack (1) · Carnegie Pharmaceuticals, LLC (1) · Golden State Medical Supply, Inc. (1) · Hikma Pharmaceuticals USA Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.3597
Range $0.3597–$0.3597 · middle 50% $0.3597–$0.3597 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.